Distributions of all expression values and Top 1% of expressed ActiveIntronRegion features for libraries: Sutent, Control

Distribution of log2 expression values for library: Sutent and data type: ActiveIntronRegion

Distribution of all expression values for the feature type: ActiveIntronRegion. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here

Distribution of log2 expression values for library: Control and data type: ActiveIntronRegion

Top 1% of expressed ActiveIntronRegion features

The following table provides a ranked list of the most highly expressed ActiveIntronRegion features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).

RANK	Sutent (Gene \| Feature \| Exp \| % Exp)	Control (Gene \| Feature \| Exp \| % Exp)
1	TMBIM6 \| I10_AR1 \| 10.17 \| 83.62%	TMBIM6 \| I10_AR1 \| 10.23 \| 83.57%
2	SEMA4B \| I15_AR1 \| 9.99 \| 172.77%	SEMA4B \| I15_AR1 \| 9.74 \| 128.74%
3	TPM4 HSH2D \| Ix_AR1 \| 9.42 \| 96.45%	ATP1B1 \| I1_AR1 \| 9.34 \| 58.88%
4	C17orf45 \| I1_AR1 \| 9.39 \| 46.21%	ZFP36L1 \| I2_AR1 \| 9.31 \| 229.52%
5	ZFP36L1 \| I2_AR1 \| 9.24 \| 271.20%	SOD2 \| I5_AR2 \| 9.22 \| 93.83%
6	SOD2 \| I5_AR2 \| 9.08 \| 105.22%	PADI1 \| I2_AR1 \| 8.99 \| 68.24%
7	BID \| I2_AR5 \| 8.81 \| 994.32%	TSPAN14 \| I13_AR1 \| 8.99 \| 72.21%
8	TSPAN14 \| I13_AR1 \| 8.74 \| 55.18%	TPM4 HSH2D \| Ix_AR1 \| 8.97 \| 83.15%
9	AC121493.1 \| I1_AR39 \| 8.73 \| 5190.97%	JAM3 \| I1_AR7 \| 8.79 \| 15026.45%
10	AC121493.1 \| I1_AR38 \| 8.73 \| 5190.97%	HNRNPL \| I10_AR1 \| 8.42 \| 52.67%
11	JAM3 \| I1_AR7 \| 8.48 \| 8499.74%	C20orf133 \| I20_AR1 \| 8.38 \| 220.95%
12	KHSRP \| I19_AR1 \| 8.33 \| 99.94%	BID \| I2_AR5 \| 8.29 \| 785.99%
13	TFE3 \| I13_AR1 \| 8.31 \| 214.18%	KHSRP \| I19_AR1 \| 8.25 \| 101.82%
14	DDX5 \| I11_AR1 \| 8.31 \| 34.41%	VAV3 \| I18_AR3 \| 8.24 \| 165.23%
15	H2AFX \| I1_AR1 \| 8.31 \| 84.23%	BAT1 \| I9_AR1 \| 8.18 \| 44.68%
16	SOD2 \| I5_AR3 \| 8.20 \| 57.30%	DDX17 \| I12_AR1 \| 8.14 \| 77.32%
17	PAX8 \| I10_AR2 \| 8.11 \| 46.30%	PADI1 \| I2_AR2 \| 8.07 \| 35.93%
18	ECH1 \| I2_AR1 \| 8.10 \| 317.26%	TFE3 \| I13_AR1 \| 8.07 \| 165.44%
19	PADI1 \| I2_AR1 \| 8.10 \| 36.83%	AC016683.7 PAX8 \| Ix_AR5 \| 8.04 \| 46.28%
20	HNRNPL \| I11_AR1 \| 8.09 \| 34.03%	C1orf186 \| I1_AR6 \| 8.04 \| 84.63%
21	HNRNPL \| I10_AR1 \| 8.08 \| 33.99%	PAX8 \| I10_AR2 \| 8.03 \| 45.87%
22	AHCYL1 \| I18_AR1 \| 8.08 \| 152.32%	SOD2 \| I5_AR3 \| 8.03 \| 40.98%
23	HNRNPL \| I9_AR2 \| 8.08 \| 33.96%	HNRNPL \| I9_AR2 \| 8.03 \| 39.91%
24	ACADVL \| I10_AR1 \| 8.04 \| 45.10%	HNRNPL \| I11_AR1 \| 7.99 \| 38.93%
25	ECH1 \| I1_AR2 \| 7.99 \| 292.92%	ECH1 \| I2_AR1 \| 7.97 \| 420.06%
26	SLCO4A1 \| I12_AR1 \| 7.92 \| 39.56%	PRODH \| I5_AR1 \| 7.96 \| 32.03%
27	BAT1 \| I9_AR1 \| 7.89 \| 33.37%	F3 \| I1_AR2 \| 7.89 \| 25.82%
28	C1orf186 \| I1_AR6 \| 7.87 \| 97.23%	GLG1 \| I26_AR1 \| 7.86 \| 103.86%
29	GLG1 \| I26_AR1 \| 7.84 \| 114.11%	DDX5 \| I11_AR1 \| 7.85 \| 30.80%
30	MUC1 \| I7_AR2 \| 7.79 \| 24.22%	AC016683.7 PAX8 \| Ix_AR2 \| 7.84 \| 40.33%
31	TNNT1 \| I3_AR1 \| 7.77 \| 36.69%	UQCRH \| I2_AR1 \| 7.83 \| 26.52%
32	C1orf186 \| I1_AR3 \| 7.77 \| 90.32%	PSMB2 \| I6_AR1 \| 7.82 \| 36.54%
33	UGT2B11 AC021146.7 \| Ix_AR12 \| 7.75 \| 67958.43%	TNNT1 \| I3_AR1 \| 7.79 \| 50.41%
34	SLC16A5 \| I6_AR3 \| 7.72 \| 125.62%	HNRNPL \| I13_AR1 \| 7.79 \| 33.76%
35	VAV3 \| I18_AR3 \| 7.69 \| 108.31%	JAM3 \| I1_AR6 \| 7.78 \| 7421.82%
36	PRODH \| I5_AR1 \| 7.69 \| 25.98%	UQCRH \| I2_AR2 \| 7.77 \| 25.52%
37	DDX17 \| I12_AR1 \| 7.69 \| 47.86%	UGT2B11 AC021146.7 \| Ix_AR12 \| 7.76 \| 113748.02%
38	JAM3 \| I1_AR6 \| 7.66 \| 4799.83%	PAX8 \| I10_AR1 \| 7.69 \| 36.29%
39	PSMB2 \| I6_AR1 \| 7.63 \| 27.66%	PADI1 \| I14_AR1 \| 7.66 \| 27.10%
40	SLC16A5 \| I6_AR1 \| 7.57 \| 112.96%	ACADVL \| I10_AR1 \| 7.66 \| 42.82%
41	PRODH \| I6_AR1 \| 7.56 \| 23.65%	H2AFX \| I1_AR1 \| 7.66 \| 67.23%
42	MICAL2 \| I27_AR1 \| 7.53 \| 437.06%	SLCO4A1 \| I12_AR1 \| 7.64 \| 46.57%
43	C20orf133 \| I20_AR1 \| 7.50 \| 130.70%	AHCYL1 \| I18_AR1 \| 7.63 \| 90.82%
44	C16orf7 \| I2_AR3 \| 7.49 \| 445.43%	AC016683.7 PAX8 \| Ix_AR1 \| 7.58 \| 33.66%
45	HNRNPL \| I13_AR1 \| 7.49 \| 22.43%	CCDC57 \| I23_AR2 \| 7.53 \| 487.35%
46	EIF4A2 \| I10_AR1 \| 7.47 \| 22.29%	AC121493.1 \| I1_AR39 \| 7.52 \| 2092.05%
47	SFRS5 \| I5_AR1 \| 7.45 \| 38.23%	AC121493.1 \| I1_AR38 \| 7.52 \| 2092.05%
48	PADI1 \| I14_AR1 \| 7.42 \| 22.95%	ECH1 \| I1_AR2 \| 7.50 \| 302.07%
49	OAS3 \| I15_AR1 \| 7.39 \| 245.42%	C6orf62 \| I1_AR1 \| 7.48 \| 109.75%
50	RCC1 \| I3_AR1 \| 7.38 \| 70.35%	SLC25A29 \| I2_AR3 \| 7.46 \| 41.04%
51	ATP1B1 \| I1_AR1 \| 7.38 \| 21.15%	PRODH \| I8_AR1 \| 7.46 \| 22.70%
52	AC121493.1 \| I1_AR37 \| 7.36 \| 1996.53%	MDM2 \| I1_AR1 \| 7.46 \| 138.46%
53	PAX8 \| I10_AR1 \| 7.35 \| 27.30%	AC016683.7 PAX8 \| Ix_AR4 \| 7.44 \| 30.35%
54	C6orf62 \| I1_AR1 \| 7.34 \| 66.57%	C1orf186 \| I1_AR5 \| 7.41 \| 54.57%
55	PRODH \| I8_AR1 \| 7.34 \| 20.32%	PRODH \| I6_AR1 \| 7.39 \| 21.60%
56	TMEM49 \| I10_AR2 \| 7.34 \| 35.60%	C1orf186 \| I1_AR3 \| 7.38 \| 53.73%
57	SLC16A5 \| I6_AR2 \| 7.34 \| 96.22%	AC008267.6 \| I3_AR1 \| 7.38 \| 811.61%
58	TSPAN16 \| I6_AR3 \| 7.28 \| 59000.69%	AC008267.6 \| I3_AR3 \| 7.36 \| 800.00%
59	CXCL1 \| I3_AR2 \| 7.24 \| 83.01%	NFKBIZ \| I11_AR1 \| 7.32 \| 78.77%
60	NOL5A \| I12_AR1 \| 7.23 \| 26.99%	SLC25A29 \| I2_AR5 \| 7.32 \| 37.17%
61	SLC25A29 \| I2_AR5 \| 7.22 \| 36.83%	SLC16A5 \| I6_AR3 \| 7.31 \| 92.10%
62	MPRIP \| I9_AR2 \| 7.16 \| 71.28%	TMEM49 \| I10_AR2 \| 7.30 \| 41.87%
63	C1orf186 \| I1_AR5 \| 7.16 \| 59.01%	CPT1A \| I19_AR1 \| 7.28 \| 112.19%
64	C11orf48 \| I5_AR1 \| 7.15 \| 81.41%	SLC25A29 \| I2_AR4 \| 7.27 \| 36.02%
65	AC016683.7 PAX8 \| Ix_AR2 \| 7.11 \| 23.00%	OAS3 \| I15_AR1 \| 7.23 \| 153.12%
66	RPL7 \| I2_AR1 \| 7.08 \| 1265.98%	DDX17 \| I11_AR1 \| 7.22 \| 40.92%
67	CDKN2AIPNL \| I3_AR1 \| 7.05 \| 165.02%	CXCL1 \| I3_AR2 \| 7.21 \| 43.07%
68	CPT1A \| I19_AR1 \| 7.01 \| 121.87%	SSBP1 \| I1_AR1 \| 7.17 \| 40.86%
69	PSMA8 DHFR \| Ix_AR1 \| 6.99 \| 109.70%	C20orf133 \| I15_AR1 \| 7.14 \| 93.29%
70	SEMA4D \| I1_AR3 \| 6.97 \| 207.61%	EIF4A2 \| I10_AR1 \| 7.14 \| 26.56%
71	SFRS7 \| I4_AR1 \| 6.94 \| 42.15%	SERINC5 \| I11_AR2 \| 7.12 \| 114.98%
72	VEGF \| I4_AR1 \| 6.91 \| 22.24%	SLC25A29 \| I2_AR1 \| 7.10 \| 31.81%
73	LENG8 \| I15_AR1 \| 6.90 \| 95.88%	VEGF \| I6_AR1 \| 7.09 \| 30.78%
74	SLC25A29 \| I2_AR2 \| 6.86 \| 28.61%	SLC25A29 \| I2_AR2 \| 7.08 \| 31.50%
75	SLC25A29 \| I2_AR3 \| 6.86 \| 28.54%	C1orf186 \| I1_AR2 \| 7.07 \| 43.01%
76	RAP1B \| I1_AR17 \| 6.85 \| 315.35%	SYT5 \| I6_AR1 \| 7.06 \| 422.53%
77	PTPRG \| I1_AR38 \| 6.85 \| 509.57%	MPRIP \| I9_AR2 \| 7.02 \| 72.21%
78	LIPA \| I3_AR2 \| 6.84 \| 134.77%	MICAL2 \| I27_AR1 \| 7.01 \| 227.98%
79	VEGF \| I6_AR1 \| 6.84 \| 21.17%	NQO2 \| I1_AR3 \| 6.99 \| 108.05%
80	CPT1A \| I19_AR2 \| 6.84 \| 108.29%	C1orf106 \| I1_AR2 \| 6.99 \| 50.90%
81	AC008267.6 \| I3_AR1 \| 6.81 \| 636.27%	RPL7 \| I2_AR1 \| 6.96 \| 1217.63%
82	HNRNPH1 \| I4_AR1 \| 6.81 \| 34.90%	C16orf7 \| I2_AR3 \| 6.93 \| 292.13%
83	ILF3 \| I11_AR1 \| 6.79 \| 40.72%	SLC16A5 \| I6_AR2 \| 6.90 \| 69.42%
84	SLC25A29 \| I2_AR1 \| 6.78 \| 27.00%	MYO1E \| I1_AR11 \| 6.89 \| 49.10%
85	CUGBP1 \| I14_AR1 \| 6.76 \| 69.09%	TSPAN16 \| I6_AR3 \| 6.88 \| 7244.30%
86	C20orf133 \| I15_AR1 \| 6.75 \| 77.51%	KSR1 \| I20_AR1 \| 6.87 \| 140.07%
87	C16orf7 \| I5_AR1 \| 6.75 \| 265.23%	LRRC41 \| I1_AR3 \| 6.86 \| 33.11%
88	SLC25A29 \| I2_AR4 \| 6.74 \| 26.26%	LENG8 \| I15_AR1 \| 6.85 \| 93.18%
89	SERINC5 \| I11_AR2 \| 6.73 \| 126.43%	SFRS5 \| I5_AR1 \| 6.84 \| 36.08%
90	ELAVL1 \| I1_AR1 \| 6.72 \| 119.67%	SLC16A5 \| I6_AR1 \| 6.84 \| 66.62%
91	KIAA0586 \| I16_AR1 \| 6.72 \| 1215.30%	ITGAE \| I27_AR2 \| 6.83 \| 1026.62%
92	PSMA8 \| I4_AR1 \| 6.72 \| 69330.37%	FAM152B \| I5_AR2 \| 6.82 \| 92.25%
93	RAX2 C19orf28 C19orf71 \| Ix_AR2 \| 6.70 \| 67.07%	SCNN1A \| I1_AR1 \| 6.81 \| 39.68%
94	MTA1 \| I18_AR2 \| 6.70 \| 52.14%	ILF3 \| I11_AR1 \| 6.80 \| 40.50%
95	SFRS14 \| I11_AR2 \| 6.69 \| 134.49%	RCC1 \| I3_AR1 \| 6.80 \| 48.04%
96	FAM62B \| I13_AR5 \| 6.66 \| 97.25%	C1RL \| I5_AR2 \| 6.77 \| 110.63%
97	ECH1 \| I1_AR1 \| 6.64 \| 114.33%	C16orf7 \| I7_AR1 \| 6.75 \| 257.95%
98	NQO2 \| I1_AR3 \| 6.64 \| 67.88%	SERINC5 \| I11_AR1 \| 6.75 \| 88.65%
99	AC008267.6 \| I3_AR3 \| 6.63 \| 561.28%	GNAL \| I6_AR7 \| 6.71 \| 1795.07%
100	LENG8 \| I16_AR1 \| 6.63 \| 79.45%	SEMA4D \| I1_AR3 \| 6.71 \| 137.33%

RANK	Sutent (Gene \| Feature \| Exp \| % Exp)	Control (Gene \| Feature \| Exp \| % Exp)
1	TMBIM6 \| I10_AR1 \| 10.17 \| 83.62%	TMBIM6 \| I10_AR1 \| 10.23 \| 83.57%
2	SEMA4B \| I15_AR1 \| 9.99 \| 172.77%	SEMA4B \| I15_AR1 \| 9.74 \| 128.74%
3	TPM4 HSH2D \| Ix_AR1 \| 9.42 \| 96.45%	ATP1B1 \| I1_AR1 \| 9.34 \| 58.88%
4	C17orf45 \| I1_AR1 \| 9.39 \| 46.21%	ZFP36L1 \| I2_AR1 \| 9.31 \| 229.52%
5	ZFP36L1 \| I2_AR1 \| 9.24 \| 271.20%	SOD2 \| I5_AR2 \| 9.22 \| 93.83%
6	SOD2 \| I5_AR2 \| 9.08 \| 105.22%	PADI1 \| I2_AR1 \| 8.99 \| 68.24%
7	BID \| I2_AR5 \| 8.81 \| 994.32%	TSPAN14 \| I13_AR1 \| 8.99 \| 72.21%
8	TSPAN14 \| I13_AR1 \| 8.74 \| 55.18%	TPM4 HSH2D \| Ix_AR1 \| 8.97 \| 83.15%
9	AC121493.1 \| I1_AR39 \| 8.73 \| 5190.97%	JAM3 \| I1_AR7 \| 8.79 \| 15026.45%
10	AC121493.1 \| I1_AR38 \| 8.73 \| 5190.97%	HNRNPL \| I10_AR1 \| 8.42 \| 52.67%
11	JAM3 \| I1_AR7 \| 8.48 \| 8499.74%	C20orf133 \| I20_AR1 \| 8.38 \| 220.95%
12	KHSRP \| I19_AR1 \| 8.33 \| 99.94%	BID \| I2_AR5 \| 8.29 \| 785.99%
13	TFE3 \| I13_AR1 \| 8.31 \| 214.18%	KHSRP \| I19_AR1 \| 8.25 \| 101.82%
14	DDX5 \| I11_AR1 \| 8.31 \| 34.41%	VAV3 \| I18_AR3 \| 8.24 \| 165.23%
15	H2AFX \| I1_AR1 \| 8.31 \| 84.23%	BAT1 \| I9_AR1 \| 8.18 \| 44.68%
16	SOD2 \| I5_AR3 \| 8.20 \| 57.30%	DDX17 \| I12_AR1 \| 8.14 \| 77.32%
17	PAX8 \| I10_AR2 \| 8.11 \| 46.30%	PADI1 \| I2_AR2 \| 8.07 \| 35.93%
18	ECH1 \| I2_AR1 \| 8.10 \| 317.26%	TFE3 \| I13_AR1 \| 8.07 \| 165.44%
19	PADI1 \| I2_AR1 \| 8.10 \| 36.83%	AC016683.7 PAX8 \| Ix_AR5 \| 8.04 \| 46.28%
20	HNRNPL \| I11_AR1 \| 8.09 \| 34.03%	C1orf186 \| I1_AR6 \| 8.04 \| 84.63%
21	HNRNPL \| I10_AR1 \| 8.08 \| 33.99%	PAX8 \| I10_AR2 \| 8.03 \| 45.87%
22	AHCYL1 \| I18_AR1 \| 8.08 \| 152.32%	SOD2 \| I5_AR3 \| 8.03 \| 40.98%
23	HNRNPL \| I9_AR2 \| 8.08 \| 33.96%	HNRNPL \| I9_AR2 \| 8.03 \| 39.91%
24	ACADVL \| I10_AR1 \| 8.04 \| 45.10%	HNRNPL \| I11_AR1 \| 7.99 \| 38.93%
25	ECH1 \| I1_AR2 \| 7.99 \| 292.92%	ECH1 \| I2_AR1 \| 7.97 \| 420.06%
26	SLCO4A1 \| I12_AR1 \| 7.92 \| 39.56%	PRODH \| I5_AR1 \| 7.96 \| 32.03%
27	BAT1 \| I9_AR1 \| 7.89 \| 33.37%	F3 \| I1_AR2 \| 7.89 \| 25.82%
28	C1orf186 \| I1_AR6 \| 7.87 \| 97.23%	GLG1 \| I26_AR1 \| 7.86 \| 103.86%
29	GLG1 \| I26_AR1 \| 7.84 \| 114.11%	DDX5 \| I11_AR1 \| 7.85 \| 30.80%
30	MUC1 \| I7_AR2 \| 7.79 \| 24.22%	AC016683.7 PAX8 \| Ix_AR2 \| 7.84 \| 40.33%
31	TNNT1 \| I3_AR1 \| 7.77 \| 36.69%	UQCRH \| I2_AR1 \| 7.83 \| 26.52%
32	C1orf186 \| I1_AR3 \| 7.77 \| 90.32%	PSMB2 \| I6_AR1 \| 7.82 \| 36.54%
33	UGT2B11 AC021146.7 \| Ix_AR12 \| 7.75 \| 67958.43%	TNNT1 \| I3_AR1 \| 7.79 \| 50.41%
34	SLC16A5 \| I6_AR3 \| 7.72 \| 125.62%	HNRNPL \| I13_AR1 \| 7.79 \| 33.76%
35	VAV3 \| I18_AR3 \| 7.69 \| 108.31%	JAM3 \| I1_AR6 \| 7.78 \| 7421.82%
36	PRODH \| I5_AR1 \| 7.69 \| 25.98%	UQCRH \| I2_AR2 \| 7.77 \| 25.52%
37	DDX17 \| I12_AR1 \| 7.69 \| 47.86%	UGT2B11 AC021146.7 \| Ix_AR12 \| 7.76 \| 113748.02%
38	JAM3 \| I1_AR6 \| 7.66 \| 4799.83%	PAX8 \| I10_AR1 \| 7.69 \| 36.29%
39	PSMB2 \| I6_AR1 \| 7.63 \| 27.66%	PADI1 \| I14_AR1 \| 7.66 \| 27.10%
40	SLC16A5 \| I6_AR1 \| 7.57 \| 112.96%	ACADVL \| I10_AR1 \| 7.66 \| 42.82%
41	PRODH \| I6_AR1 \| 7.56 \| 23.65%	H2AFX \| I1_AR1 \| 7.66 \| 67.23%
42	MICAL2 \| I27_AR1 \| 7.53 \| 437.06%	SLCO4A1 \| I12_AR1 \| 7.64 \| 46.57%
43	C20orf133 \| I20_AR1 \| 7.50 \| 130.70%	AHCYL1 \| I18_AR1 \| 7.63 \| 90.82%
44	C16orf7 \| I2_AR3 \| 7.49 \| 445.43%	AC016683.7 PAX8 \| Ix_AR1 \| 7.58 \| 33.66%
45	HNRNPL \| I13_AR1 \| 7.49 \| 22.43%	CCDC57 \| I23_AR2 \| 7.53 \| 487.35%
46	EIF4A2 \| I10_AR1 \| 7.47 \| 22.29%	AC121493.1 \| I1_AR39 \| 7.52 \| 2092.05%
47	SFRS5 \| I5_AR1 \| 7.45 \| 38.23%	AC121493.1 \| I1_AR38 \| 7.52 \| 2092.05%
48	PADI1 \| I14_AR1 \| 7.42 \| 22.95%	ECH1 \| I1_AR2 \| 7.50 \| 302.07%
49	OAS3 \| I15_AR1 \| 7.39 \| 245.42%	C6orf62 \| I1_AR1 \| 7.48 \| 109.75%
50	RCC1 \| I3_AR1 \| 7.38 \| 70.35%	SLC25A29 \| I2_AR3 \| 7.46 \| 41.04%
51	ATP1B1 \| I1_AR1 \| 7.38 \| 21.15%	PRODH \| I8_AR1 \| 7.46 \| 22.70%
52	AC121493.1 \| I1_AR37 \| 7.36 \| 1996.53%	MDM2 \| I1_AR1 \| 7.46 \| 138.46%
53	PAX8 \| I10_AR1 \| 7.35 \| 27.30%	AC016683.7 PAX8 \| Ix_AR4 \| 7.44 \| 30.35%
54	C6orf62 \| I1_AR1 \| 7.34 \| 66.57%	C1orf186 \| I1_AR5 \| 7.41 \| 54.57%
55	PRODH \| I8_AR1 \| 7.34 \| 20.32%	PRODH \| I6_AR1 \| 7.39 \| 21.60%
56	TMEM49 \| I10_AR2 \| 7.34 \| 35.60%	C1orf186 \| I1_AR3 \| 7.38 \| 53.73%
57	SLC16A5 \| I6_AR2 \| 7.34 \| 96.22%	AC008267.6 \| I3_AR1 \| 7.38 \| 811.61%
58	TSPAN16 \| I6_AR3 \| 7.28 \| 59000.69%	AC008267.6 \| I3_AR3 \| 7.36 \| 800.00%
59	CXCL1 \| I3_AR2 \| 7.24 \| 83.01%	NFKBIZ \| I11_AR1 \| 7.32 \| 78.77%
60	NOL5A \| I12_AR1 \| 7.23 \| 26.99%	SLC25A29 \| I2_AR5 \| 7.32 \| 37.17%
61	SLC25A29 \| I2_AR5 \| 7.22 \| 36.83%	SLC16A5 \| I6_AR3 \| 7.31 \| 92.10%
62	MPRIP \| I9_AR2 \| 7.16 \| 71.28%	TMEM49 \| I10_AR2 \| 7.30 \| 41.87%
63	C1orf186 \| I1_AR5 \| 7.16 \| 59.01%	CPT1A \| I19_AR1 \| 7.28 \| 112.19%
64	C11orf48 \| I5_AR1 \| 7.15 \| 81.41%	SLC25A29 \| I2_AR4 \| 7.27 \| 36.02%
65	AC016683.7 PAX8 \| Ix_AR2 \| 7.11 \| 23.00%	OAS3 \| I15_AR1 \| 7.23 \| 153.12%
66	RPL7 \| I2_AR1 \| 7.08 \| 1265.98%	DDX17 \| I11_AR1 \| 7.22 \| 40.92%
67	CDKN2AIPNL \| I3_AR1 \| 7.05 \| 165.02%	CXCL1 \| I3_AR2 \| 7.21 \| 43.07%
68	CPT1A \| I19_AR1 \| 7.01 \| 121.87%	SSBP1 \| I1_AR1 \| 7.17 \| 40.86%
69	PSMA8 DHFR \| Ix_AR1 \| 6.99 \| 109.70%	C20orf133 \| I15_AR1 \| 7.14 \| 93.29%
70	SEMA4D \| I1_AR3 \| 6.97 \| 207.61%	EIF4A2 \| I10_AR1 \| 7.14 \| 26.56%
71	SFRS7 \| I4_AR1 \| 6.94 \| 42.15%	SERINC5 \| I11_AR2 \| 7.12 \| 114.98%
72	VEGF \| I4_AR1 \| 6.91 \| 22.24%	SLC25A29 \| I2_AR1 \| 7.10 \| 31.81%
73	LENG8 \| I15_AR1 \| 6.90 \| 95.88%	VEGF \| I6_AR1 \| 7.09 \| 30.78%
74	SLC25A29 \| I2_AR2 \| 6.86 \| 28.61%	SLC25A29 \| I2_AR2 \| 7.08 \| 31.50%
75	SLC25A29 \| I2_AR3 \| 6.86 \| 28.54%	C1orf186 \| I1_AR2 \| 7.07 \| 43.01%
76	RAP1B \| I1_AR17 \| 6.85 \| 315.35%	SYT5 \| I6_AR1 \| 7.06 \| 422.53%
77	PTPRG \| I1_AR38 \| 6.85 \| 509.57%	MPRIP \| I9_AR2 \| 7.02 \| 72.21%
78	LIPA \| I3_AR2 \| 6.84 \| 134.77%	MICAL2 \| I27_AR1 \| 7.01 \| 227.98%
79	VEGF \| I6_AR1 \| 6.84 \| 21.17%	NQO2 \| I1_AR3 \| 6.99 \| 108.05%
80	CPT1A \| I19_AR2 \| 6.84 \| 108.29%	C1orf106 \| I1_AR2 \| 6.99 \| 50.90%
81	AC008267.6 \| I3_AR1 \| 6.81 \| 636.27%	RPL7 \| I2_AR1 \| 6.96 \| 1217.63%
82	HNRNPH1 \| I4_AR1 \| 6.81 \| 34.90%	C16orf7 \| I2_AR3 \| 6.93 \| 292.13%
83	ILF3 \| I11_AR1 \| 6.79 \| 40.72%	SLC16A5 \| I6_AR2 \| 6.90 \| 69.42%
84	SLC25A29 \| I2_AR1 \| 6.78 \| 27.00%	MYO1E \| I1_AR11 \| 6.89 \| 49.10%
85	CUGBP1 \| I14_AR1 \| 6.76 \| 69.09%	TSPAN16 \| I6_AR3 \| 6.88 \| 7244.30%
86	C20orf133 \| I15_AR1 \| 6.75 \| 77.51%	KSR1 \| I20_AR1 \| 6.87 \| 140.07%
87	C16orf7 \| I5_AR1 \| 6.75 \| 265.23%	LRRC41 \| I1_AR3 \| 6.86 \| 33.11%
88	SLC25A29 \| I2_AR4 \| 6.74 \| 26.26%	LENG8 \| I15_AR1 \| 6.85 \| 93.18%
89	SERINC5 \| I11_AR2 \| 6.73 \| 126.43%	SFRS5 \| I5_AR1 \| 6.84 \| 36.08%
90	ELAVL1 \| I1_AR1 \| 6.72 \| 119.67%	SLC16A5 \| I6_AR1 \| 6.84 \| 66.62%
91	KIAA0586 \| I16_AR1 \| 6.72 \| 1215.30%	ITGAE \| I27_AR2 \| 6.83 \| 1026.62%
92	PSMA8 \| I4_AR1 \| 6.72 \| 69330.37%	FAM152B \| I5_AR2 \| 6.82 \| 92.25%
93	RAX2 C19orf28 C19orf71 \| Ix_AR2 \| 6.70 \| 67.07%	SCNN1A \| I1_AR1 \| 6.81 \| 39.68%
94	MTA1 \| I18_AR2 \| 6.70 \| 52.14%	ILF3 \| I11_AR1 \| 6.80 \| 40.50%
95	SFRS14 \| I11_AR2 \| 6.69 \| 134.49%	RCC1 \| I3_AR1 \| 6.80 \| 48.04%
96	FAM62B \| I13_AR5 \| 6.66 \| 97.25%	C1RL \| I5_AR2 \| 6.77 \| 110.63%
97	ECH1 \| I1_AR1 \| 6.64 \| 114.33%	C16orf7 \| I7_AR1 \| 6.75 \| 257.95%
98	NQO2 \| I1_AR3 \| 6.64 \| 67.88%	SERINC5 \| I11_AR1 \| 6.75 \| 88.65%
99	AC008267.6 \| I3_AR3 \| 6.63 \| 561.28%	GNAL \| I6_AR7 \| 6.71 \| 1795.07%
100	LENG8 \| I16_AR1 \| 6.63 \| 79.45%	SEMA4D \| I1_AR3 \| 6.71 \| 137.33%